Form 4: Hologic Director Garrett T. Scott Reports Acquisition of Stock and Stock Options

Director Garrett T. Scott reports acquisition of common stock and stock options in Hologic Inc.

Summary

• On March 7, 2024, Garrett T. Scott, a director of Hologic Inc., reported the acquisition of 1,572 shares of common stock.
• These shares were acquired as restricted stock units that vest on the date of the 2025 Annual Meeting of Stockholders and are settled in shares of common stock.
• Scott also acquired 4,536 non-qualified stock options with an exercise price of $76.32, which become exercisable on the date of the 2025 Annual Meeting of Stockholders and expire on March 7, 2034.
• Following these transactions, Scott directly owns 48,611 shares of Hologic Inc. common stock, which includes 4,633 restricted stock units with deferred settlement.
• He also directly owns 4,536 derivative securities in the form of non-qualified stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The acquisition of shares and options by a director could be interpreted slightly positively, suggesting confidence in the company, but it's not a strong indicator.

Positives

• The acquisition of stock and stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment, as it indicates a director's investment in the company.

Key Dates